AutoAbSC.Org — Autoantibody Standardization Committee in 2006

Tan, 1988, 1331

Fritzler, 2003, A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories, J Rheumatol, 30, 2374

Tan, 2002, A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content, J Rheumatol, 29, 68

Tan, 1999, A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity, Arthritis Rheum, 42, 455, 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3

Tincani, 2001, Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations — a cooperative project of the European Antiphospholipid Forum, Thromb Haemost, 86, 575, 10.1055/s-0037-1616089

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x

van Venrooij, 2000, Citrullination: a small change for a protein with great consequences for rheumatoid arthritis, Arthritis Res, 2, 249, 10.1186/ar95

Avouac, 2006, Diagnostic and predictive value of anti-CCP (cyclic citrullinated protein) antibodies in rheumatoid arthritis: a systematic literature review, Ann Rheum Dis, 65, 845, 10.1136/ard.2006.051391

Vencovsky, 2003, Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis, Ann Rheum Dis, 62, 427, 10.1136/ard.62.5.427

van Gaalen, 2004, Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis, Arthritis Rheum, 50, 2113, 10.1002/art.20316

Ronnelid, 2005, Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression, Ann Rheum Dis, 64, 1744, 10.1136/ard.2004.033571

Meyer, 2003, Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage, Ann Rheum Dis, 62, 120, 10.1136/ard.62.2.120

Kroot, 2000, The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, Arthritis Rheum, 43, 1831, 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6

Hueber, 2005, Antigen microarray profiling of autoantibodies in rheumatoid arthritis, Arthritis Rheum, 52, 2645, 10.1002/art.21269

Steen, 2005, Autoantibodies in systemic sclerosis, Semin Arthritis Rheum, 35, 35, 10.1016/j.semarthrit.2005.03.005

Reimer, 1987, Autoantibody to RNA polymerase I in scleroderma sera, J Clin Invest, 79, 65, 10.1172/JCI112809

Kuwana, 1993, Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis, J Clin Invest, 91, 1399, 10.1172/JCI116343

Okano, 1993, Autoantibody reactive with RNA polymerase III in systemic sclerosis, Ann Intern Med, 119, 1005, 10.7326/0003-4819-119-10-199311150-00007

Fritzler, 2003, The use and abuse of commercial kits used to detect autoantibodies, Arthritis Res Ther, 5, 192, 10.1186/ar782

Wiik, 2004, Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology, Arthritis Rheum, 51, 291, 10.1002/art.20229